Comparative evaluation of TRI-DOT Rapid HIV test with fourth-generation ELISA for the detection of human immunodeficiency virus  by Sudha, T. et al.
obtained with cell culture combined with immu-
noﬂuorescence [15], while sensitivities obtained
with rapid diagnostic immunoassays for inﬂuenza
A vary from 75% [16,17] to 100% [8,16,18].
It is accepted widely that PCR techniques are
superior to EIAs with regard to sensitivity and
speciﬁcity [18]. For a diagnosis when the preval-
ence of acute respiratory tract infection is low, i.e.,
outside the yearly epidemic season, EIAs have a
low PPV, and thus their use in diagnosis is
questionable. More accurate techniques, such as
PCR, should be used in diagnosis of virus
respiratory tract infections for epidemiological
research and intervention trials.
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ABSTRACT
This study evaluated the TRI-DOT Rapid HIV test
for the early detection of human immunodeﬁ-
ciency virus (HIV) infection in comparison with a
fourth-generation ELISA (Vironostika HIV Uni-
form II). Of 23 609 sera, seven (0.03%) gave
discordant results. Six of these were reactive only
by the fourth-generation assay and were p24
antigen-positive by VIDAS DUO, Western blot
and qualitative RT-PCR tests. The remaining
discordant serum was considered to be false-
positive by the TRI-DOT assay, as it was negative
by repeat ELISA and Western blot tests. The
sensitivity and speciﬁcity of the TRI-DOT test
were 99.48% and 99.99%, respectively, compared
with the fourth-generation ELISA.
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Early knowledge of human immunodeﬁciency
virus (HIV) serostatus is an important element in
HIV prevention and treatment. Laboratory meth-
ods for screening blood from HIV-infected indi-
viduals can be classiﬁed into those that detect
antibody, identify antigen, monitor virus nucleic
acid or provide an estimate of CD4 cell counts [1].
Ideally, to maximise the detection of all infected
individuals, especially during the period follow-
ing exposure or in the early stages of infection
before antibody is detectable, antigen and virus
RNA tests should be used. As virus RNA tests are
expensive, time-consuming, and not available in
many laboratories, fourth-generation ELISAs have
been designed to detect anti-HIV immunoglobulin
and HIV core protein p24 antigen simultaneously
in order to screen for both the early and late phases
of infection. These newELISAs have the advantage
of decreasing the diagnostic window (mean reduc-
tion of 4–7 days), personnel and costs in compar-
ison with the requirements for performing each
assay individually [2–9]. The detection of early
infection has been shown to be beneﬁcial for the
initiation of treatment and counselling of infected
individuals, and for the institution of interventions
to reduce the risk of further transmission.
With the introduction in India of the concept of
point-of-care testing and Voluntary Counselling
and Testing Centres, several rapid tests for HIV
have been developed that are low-cost and easy to
perform. Several previous reports have compared
fourth- and third-generation ELISAs [5–9], or two
or more rapid HIV tests [10,11], but there are few
reports that compare the performance of rapid
HIV tests with fourth-generation ELISAs for the
detection of HIV in patients’ sera. As > 30% of
HIV tests in our institute are requested for
emergency purposes, and are thus rapid HIV
tests, the present study evaluated the TRI-DOT
Rapid HIV ﬂow-through test (Mitra & Co., New
Delhi, India) in comparison with a fourth-genera-
tion ELISA (Vironostika HIV Uni-Form II Ag ⁄Ab;
bioMe´rieux, Marcy l’Etoile, France) for the early
detection of HIV infection.
Between January 2003 and April 2004, 23 609
sera were received from various units of our
institute for HIV testing. Rapid HIV testing using
the TRI-DOT kit was requested for 7913 (33.5%) of
these sera because of various emergency situa-
tions. This kit is a ﬂow-through device with an
inbuilt internal control and two separate antigen
dots for HIV-1 and HIV-2. All these sera, irres-
pective of their HIV status, were also retested by
the fourth-generation ELISA Vironostika HIV Uni-
Form II Ag ⁄Ab assay. The remaining 15 696
‘routine’ sera were screened with the fourth-
generation ELISA, and were retested with the
TRI-DOT kit. Both test procedures were per-
formed according to the manufacturers’ instruc-
tions. For the calculation of sensitivity and
speciﬁcity, sera were considered to be ‘true-pos-
itives’ when they were positive by both assays. In
the case of discordance, sera were retested by
Western blot (General Biological Corporation,
Taipei, Taiwan), the VIDAS HIV DUO assay
(bioMe´rieux), and qualitative RT-PCR (Amplicor
HIV-1; Roche Diagnostics, Mannheim, Germany).
Samples were considered non-reactive when both
the TRI-DOT and ELISA tests were negative.
Of 23 609 sera tested, 22 459 (95.1%) were non-
reactive, and 1145 (4.8%) were positive by both
assays. There were seven (0.03%) discordant sera,
of which six were reactive only by the fourth-
generation ELISA and were Western blot-negat-
ive, but were p24 antigen-positive by the VIDAS
HIV DUO assay; thus they could not be detected
by the TRI-DOT assay. Four of these six sera were
also positive by qualitative RT-PCR, while the
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remaining two could not be assayed by RT-PCR.
One discordant sample that was reactive only by
the TRI-DOT assay was non-reactive by repeat
ELISA, Western blot, VIDAS DUO and RT-PCR;
this was considered to be a false-positive result by
the TRI-DOT kit. Thus, compared with the fourth-
generation ELISA, the TRI-DOT Rapid HIV test
had a speciﬁcity of 99.9% and a sensitivity of
99.5%. The overall prevalence of HIV-1 and HIV-2
in the sera studied was 4.7% and 0.2%, respect-
ively, and 19 (1.7%) of the 1150 HIV-positive
patients were infected with both HIV-1 and HIV-2.
The CDC has advocated routine testing of
patients for HIV as a means of increasing provider
vigilance and reducing occupational exposure [12].
The results are also helpful in making patients
aware of their infection and enabling appropriate
treatment and counselling [12,13]. Early diagnosis
of HIV infection is the cornerstone of prevention
and care strategies for HIV-infected individuals.
The rapid test used in the present study only
detects HIV antibodies, and not the p24 antigen;
thus there is always the possibility of missing a
recent infection when the p24 antigen is present,
but without any detectable antibody levels. The
results of the study indicated that the TRI-DOT
HIV test failed to detect only six (0.5%) of 1150
reactive sera; these six sera were presumably from
patients who were in the early stages of infection.
Thus the TRI-DOTHIV Rapid assay, which gives a
result within 10 min, can be used in emergency
situations when there is insufﬁcient time to per-
form a fourth-generation ELISA. However, the
results should later be conﬁrmed by ELISA to rule
out the possibility of early infection. The two tests
showed good sensitivity for bothHIV-1 andHIV-2.
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